
EASD
@EASDnews
Followers
14K
Following
7K
Media
1K
Statuses
8K
We promote excellence in #diabetes care through #research, #networking and #education. Privacy Policy: https://t.co/a3EApfcoFV
Düsseldorf, Germany
Joined October 2009
💡Can we predict #type2diabetes before it begins? Dr @mezza_teresa , recipient of the 60th EASD #Minkowski Prize, shares how studying patients after partial pancreatectomy reveals early biomarkers that could transform prevention. 🎧👉 https://t.co/PIyXuwTybq
#Pancreas #Podcasts
0
4
12
⏰The #EASD2025 Virtual Meeting Platform closes on 17 Oct! Last chance to catch up on the groundbreaking science & earn #CME credits. Enjoy a look at #easd2025 by the numbers👇 Log in with your MyEASD credentials before it closes - https://t.co/3swgdLrS8I
#medicaleducation
0
2
5
📢EASD will host its 1st Immunology School for Endocrinology: #Immunology in #Type1Diabetes - bridging the science and clinical impact. 📅 26 - 27 March 2026 |📍Vienna, Austria Open to EASD Members in endocrinology/diabetology. Learn more & apply here 👉 https://t.co/iGpBh7nQuQ
1
3
5
👀Today, on #WorldSightDay , we spotlight the link between #diabetes & #vision. Diabetic #retinopathy is a leading cause of blindness, yet often preventable with early screening & good diabetes management. 👁 Early action saves. Protect your vision. #WSD2025 #LoveYourEyes
2
2
10
✈️👉How well does #ditech perform in the air? @MadderJules explains how her @EASA -backed project is testing #CGM and #AID at altitude, and why this could reshape aviation rules. Watch this #ExpertInsights episode here: https://t.co/d2zPW8B1TC
#Diabetes #Technology #aviation
1
2
7
🎓Great Opportunity for #earlycareer #diabetes researchers & clinicians! The @EASDacademy Mentorship Programme is now open for applications! If you’re looking to advance your career in diabetes research, apply by 3 Nov 2025, 12:00 CET. 🔗👉
🎓 New Call: Join our #Mentorship Programme now❗ Highlights: ✅1-year mentorship ✅Up to €1,000 travel support p.a. Apply by 3 Nov 2025, 12:00 CET Don’t miss this opportunity to grow your expertise and build your network in the #diabetes field! 🔗👉 https://t.co/yzDACz8Srf
0
4
8
🧠Meet Prof. Claudia Cavelti-Weder, #EFSD Future Leaders Mentorship Grant Recipient. Her iMAC study reveals immune reprogramming in intestinal macrophages in #obesity uncovering gut-metabolic links&early bariatric biomarkers. 📖 https://t.co/Ptqr2EJg6x Supported by @AstraZeneca
0
1
6
🗣️ Have your say! At #EASD2025, the updated EASD-ADA draft #consensusreport on managing #type1diabetes in adults was presented. The committee are requesting your input before it is finalised. Submit your comments by 16 October 2025 at 23:59 ET 👉
📢 In case you missed it: At #EASD2025, Richard Holt & Anne Peters presented the updated @EASDnews & @AmDiabetesAssn consensus report on adult #type1diabetes care. Now open for consultation - review & share your feedback via QR code or link 👉 https://t.co/9Mq4znkgOt
#T1D
1
4
10
📢 Don’t miss the @EASDacademy #webinar : "High-res approaches to study white adipose tissue w/ Profs. @nikmejhert & @ryden_mikael (@karolinskainst) 📅 14 Oct 2025 | 🕛 17:00 CEST Register now to reserve your spot 🔗👉 https://t.co/iXpXI6kROu
#EarlyCareer #Diabetes #Obesity
us06web.zoom.us
In this EASD Early Career Academy Webinar, Niklas Mejhert and Mikael Rydén from the Karolinska Institutet in Sweden, will describe how high-resolution spatial approaches applied to human white...
📢New Webinar Alert with Professors @nikmejhert & @ryden_mikael from the @karolinskainst: 📅14 Oct 2025 | 🕛17:00 CEST See how high-res spatial analyses uncover adipose cell organisation & insights into health & cardiometabolic disease. 🔗Register now: https://t.co/hZXyYWJKJv
1
0
4
🗣️ Listen in as EASD President, Prof. Chantal Mathieu discusses the MELD-ATG #trial results on antithymocyte globulin in 5 - 25 y/o with #t1d, presented at #EASD2025 in Vienna. 📖 Published in @TheLancet : https://t.co/3Fgeb3eoQZ 🎥 Full interview:
springermedicine.com
Prof. Chantal Mathieu shares the results of the MELD-ATG trial demonstrating that a low dose of antithymocyte globulin reduces loss of beta cell
From #EASD2025 - Prof. Chantal Mathieu shares the results of the MELD-ATG trial demonstrating that a low dose of antithymocyte globulin reduces loss of beta cell function in patients aged 5-25 years old who have a recent diagnosis of stage 3 #T1D. 👉 https://t.co/sKNviwsiCb
0
2
4
⏰Applications close soon! We’re still hiring for an #ExecutiveAssistant to work with EASD leadership & advance our mission! ✅Organised, structured, strong communicator - we encourage you to apply! 📅Apply by 9 Oct 2025👉 https://t.co/1NbQpcZRAn
#JoinOurTeam #Hiring #diabetes
🌟We’re #hiring! #ExecutiveAssistant to support EASD leadership & drive our mission forward ✅Organised, structured, strong communicator 📅Coordinate meetings & keep things running smoothly 📩Apply by 9 Oct 2025: https://t.co/1NbQpcZRAn
#CareerOpportunity #JoinOurTeam
0
0
2
💥🎙️ New Episode!!! Prof. Andrew Hattersley, 57th EASD Claude Bernard #Prize recipient, shares how his work on #genetic forms of diabetes has transformed care worldwide & what’s next for #PrecisionMedicine . 🎧 Listen now: https://t.co/CZz44eLB0z
#Diabetes #Research #podcast
0
2
13
🥁New #DiabetesPerspectives: @RichardIGHolt @janespeight @MichelleLawT1D: Decoding the 1st EASD guideline on #diabetesdistress 🎯evidence-based strategies for the emotional side of living w. #diabetes presented at #EASD2025. 📺 https://t.co/s010wFr2Qo ✍️ https://t.co/gKu4PK29hi
1
4
15
📢 An international multidisciplinary task force (@aace ,Canadian Cardiovascular Society, ALALIP & @EASDnews ) has released an updated #consensusstatement on the 2020 AACE dyslipidemia algorithm. Representing EASD: Prof. Fredrik Karpe ( @UniofOxford) 🔗👉 https://t.co/i3YCsyAcIT
endocrinepractice.org
To provide visual guidance in concise algorithms and tables to assist with clinical decision making in the management of adults with dyslipidemia to reduce risk of ASCVD and triglyceride-induced...
The official published American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update is now available! Read the algorithm: https://t.co/Ggzo7tKBIP
#endocrinology @EASDnews
0
0
5
Meet Dr. Frank Ning (@karolinskainst ), #EFSD/@LillyDiabetesIn Young Investigator Awardee. His work targets VEGF-B in adipose tissue to combat diabetic cardiomyopathy showing inhibition reduces lipotoxicity, fibrosis & improves heart function in #T2D. 📖👉 https://t.co/9MUYSsVKN4
0
0
3
📣 Still open: We're hiring an #ExecutiveAssistant to support EASD leadership. ✅Organised, great communicator, multitasker? This could be the role for you! 🗓Applications close on 9 Oct 2025 Learn more👉 https://t.co/1NbQpcZRAn
#Diabetes #hiring #JoinOurTeam #jobopportunity
🌟We’re #hiring! #ExecutiveAssistant to support EASD leadership & drive our mission forward ✅Organised, structured, strong communicator 📅Coordinate meetings & keep things running smoothly 📩Apply by 9 Oct 2025: https://t.co/1NbQpcZRAn
#CareerOpportunity #JoinOurTeam
0
1
3
🚨New Journal launched at #EASD2025 in Vienna! Introducing @Metabologia - sister journal to @Diabetologia, peer-reviewed, open-access, obesity & metabolic health; from basic science to clinical trials, reviews & even negative findings. Learn more 👉 https://t.co/5g2Q4JHs3h
1
0
4
❤️Today is #WorldHeartDay! #Diabetes is a major risk factor for #cardiovasculardisease (CVD). 📚Our e-Learning course covers #CVD in type 1 & type 2 diabetes - from coronary heart disease to stroke, heart failure & vascular disease. 🔗Learn more: https://t.co/BoAumAcMfe
1
2
6
🎶Have you heard it yet? #EASD2025 inspired its own song! If you missed it in Vienna, now’s your chance to listen. A tune to lift your spirits & celebrate our shared commitment to advancing #DiabetesResearch. Listen Now👇 #EASD #Diabetes #MedicalCommunity #music
0
3
6
🎙️The EASDtv podcast is back! 11th EASD-NNF Diabetes Prize for Excellence recipient, Prof. Gerald Shulman, shares 40 years of groundbreaking research on insulin resistance, mitochondria & therapies that could reshape diabetes care & beyond. 🎧👉 https://t.co/CZz44eLB0z
0
0
5